Bonyf NV (MLBON) - Total Liabilities
Based on the latest financial reports, Bonyf NV (MLBON) has total liabilities worth €1.25 Million EUR (≈ $1.46 Million USD) as of September 2021. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bonyf NV - Total Liabilities Trend (2019–2024)
This chart illustrates how Bonyf NV's total liabilities have evolved over time, based on quarterly financial data. See Bonyf NV (MLBON) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Bonyf NV Competitors by Total Liabilities
The table below lists competitors of Bonyf NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coppermoly Ltd
AU:COY
|
Australia | AU$338.99K |
|
Odd Burger Corp
V:ODD
|
Canada | CA$6.70 Million |
|
OurLiving AB
ST:OURLIV
|
Sweden | Skr8.99 Million |
|
Aethlon Medical Inc
NASDAQ:AEMD
|
USA | $1.34 Billion |
|
Gabather AB (publ)
ST:GABA
|
Sweden | Skr4.20 Million |
|
Capricorn Energy PLC
LSE:CNE
|
UK | GBX139.75 Million |
|
NAYA Biosciences, Inc
NASDAQ:NAYA
|
USA | $33.70 Million |
|
China Pharma Holdings Inc
NYSE MKT:CPHI
|
USA | $7.49 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Bonyf NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bonyf NV market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bonyf NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bonyf NV (2019–2024)
The table below shows the annual total liabilities of Bonyf NV from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €696.48K ≈ $814.26K |
+69.08% |
| 2023-12-31 | €411.94K ≈ $481.60K |
-7.42% |
| 2022-12-31 | €444.97K ≈ $520.22K |
-59.53% |
| 2020-12-31 | €1.10 Million ≈ $1.29 Million |
+5.59% |
| 2019-12-31 | €1.04 Million ≈ $1.22 Million |
-- |
About Bonyf NV
bonyf N.V. engages in the research, development, production, and distribution of oral and dental products in Belgium and internationally. The company offers PerioTabs, a brushing solution for gums, teeth, and dental implants to help reduce gingivitis, periodontitis, peri-mucositis, and peri-implantitis; and AphtoFix, a film-forming cream for the local treatment of mouth ulcers. It also provides d… Read more